Medclair AB (NGM:MCLR)

Market Cap	226.85M
Revenue (ttm)	50.04M
Net Income (ttm)	5.22M
Shares Out	82.49M
EPS (ttm)	0.07
PE Ratio	40.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,281
Average Volume	93,720
Open	n/a
Previous Close	2.760
Day's Range	n/a
52-Week Range	1.215 - 3.350
Beta	1.03
RSI	44.09
Earnings Date	Feb 20, 2026

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous O...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2008
• Employees: 14
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: MCLR

Financial Performance

In 2024, Medclair AB's revenue was 35.95 million, a decrease of -15.25% compared to the previous year's 42.42 million. Losses were -664,000, -76.16% less than in 2023.